Only 1.5% of commercially insured individuals at high risk for an opioid overdose were prescribed the overdose medication naloxone, despite having multiple interactions with the health care system, according to a retrospective cohort study.
“However, patients who had both a history of opioid overdose and a diagnosis of opioid use disorder were more than twice as likely to be prescribed naloxone than those that had only the diagnosis of opioid use disorder,” said principal